Thanks XC (After the drug failed the shares dropped 62% , company now valued $28 million ) here is another company with a failed drug that is still valued close to SSH at its lows last week, the market will wake up soon enough.
Update US Study, page-33
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)